|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1 to 100 out of 1236 for Cdkn2a

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.026s

Categories

Category: Publication
Type Details Score
Publication  
First Author: Rabhi N
Year: 2018
Journal: Mol Metab
Title: Cdkn2a deficiency promotes adipose tissue browning.
Volume: 8
Pages: 65-76
Publication
First Author: Rhodes SD
Year: 2019
Journal: Hum Mol Genet
Title: Cdkn2a (Arf) loss drives NF1-associated atypical neurofibroma and malignant transformation.
Volume: 28
Issue: 16
Pages: 2752-2762
Publication
First Author: Ortiz B
Year: 2014
Journal: Oncotarget
Title: Deletion of Ptprd and Cdkn2a cooperate to accelerate tumorigenesis.
Volume: 5
Issue: 16
Pages: 6976-82
Publication
First Author: Kuo CL
Year: 2011
Journal: Arterioscler Thromb Vasc Biol
Title: Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation.
Volume: 31
Issue: 11
Pages: 2483-92
Publication
First Author: Adorno M
Year: 2018
Journal: Sci Rep
Title: Usp16 modulates Wnt signaling in primary tissues through Cdkn2a regulation.
Volume: 8
Issue: 1
Pages: 17506
Publication
First Author: Takeda S
Year: 2015
Journal: J Clin Invest
Title: Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.
Volume: 125
Issue: 3
Pages: 1203-14
Publication
First Author: Li J
Year: 2022
Journal: PLoS Pathog
Title: The Cdkn2a gene product p19 alternative reading frame (p19ARF) is a critical regulator of IFNβ-mediated Lyme arthritis.
Volume: 18
Issue: 3
Pages: e1010365
Publication
First Author: Le Chalony C
Year: 2000
Journal: Cytogenet Cell Genet
Title: Identification and mapping of swine cyclin-dependent kinase inhibitor CDKN2A and CDKN2B exon 2 sequences.
Volume: 88
Issue: 3-4
Pages: 240-3
Publication
First Author: Brandt LP
Year: 2017
Journal: PLoS One
Title: Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma.
Volume: 12
Issue: 10
Pages: e0186102
Publication
First Author: Miyazaki M
Year: 2008
Journal: Immunity
Title: Thymocyte proliferation induced by pre-T cell receptor signaling is maintained through polycomb gene product Bmi-1-mediated Cdkn2a repression.
Volume: 28
Issue: 2
Pages: 231-45
Publication    
First Author: Jing J
Year: 2019
Journal: Elife
Title: Antagonistic interaction between Ezh2 and Arid1a coordinates root patterning and development via Cdkn2a in mouse molars.
Volume: 8
Publication
First Author: Yang H
Year: 2017
Journal: Oncogene
Title: Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma.
Volume: 36
Issue: 27
Pages: 3842-3851
Publication
First Author: Zhang Z
Year: 2021
Journal: FASEB J
Title: CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis.
Volume: 35
Issue: 4
Pages: e21230
Publication
First Author: Li Z
Year: 2016
Journal: J Pathol
Title: Cdkn2a suppresses metastasis in squamous cell carcinomas induced by the gain-of-function mutant p53(R172H).
Volume: 240
Issue: 2
Pages: 224-34
Publication
First Author: Li X
Year: 2011
Journal: Mol Cell Biol
Title: Mammalian polycomb-like Pcl2/Mtf2 is a novel regulatory component of PRC2 that can differentially modulate polycomb activity both at the Hox gene cluster and at Cdkn2a genes.
Volume: 31
Issue: 2
Pages: 351-64
Publication
First Author: Koike H
Year: 2014
Journal: Hepatology
Title: Ring1B promotes hepatic stem/progenitor cell expansion through simultaneous suppression of Cdkn1a and Cdkn2a in mice.
Volume: 60
Issue: 1
Pages: 323-33
Publication
First Author: Herzog CR
Year: 1997
Journal: Mamm Genome
Title: Sequence variation and chromosomal mapping of the murine Cdkn2a tumor suppressor gene.
Volume: 8
Issue: 1
Pages: 65-6
Publication  
First Author: Catarino TA
Year: 2022
Journal: Exp Hematol
Title: Cdkn2a inactivation promotes malignant transformation of mouse immature thymocytes before the β-selection checkpoint.
Volume: 116
Pages: 30-36
Publication
First Author: Huillard E
Year: 2012
Journal: Proc Natl Acad Sci U S A
Title: Cooperative interactions of BRAFV600E kinase and CDKN2A locus deficiency in pediatric malignant astrocytoma as a basis for rational therapy.
Volume: 109
Issue: 22
Pages: 8710-5
Publication
First Author: Acquaviva J
Year: 2011
Journal: Cancer Res
Title: Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation.
Volume: 71
Issue: 23
Pages: 7198-206
Publication
First Author: van Weele LJ
Year: 2021
Journal: Stem Cell Reports
Title: Depletion of Trp53 and Cdkn2a Does Not Promote Self-Renewal in the Mammary Gland but Amplifies Proliferation Induced by TNF-α.
Volume: 16
Issue: 2
Pages: 228-236
Publication
First Author: Wadhwa R
Year: 2003
Journal: Exp Gerontol
Title: A novel putative collaborator of p19ARF.
Volume: 38
Issue: 3
Pages: 245-52
Publication  
First Author: Chen G
Year: 2018
Journal: Front Immunol
Title: Ezh2 Regulates Activation-Induced CD8+ T Cell Cycle Progression via Repressing Cdkn2a and Cdkn1c Expression.
Volume: 9
Pages: 549
Publication
First Author: Kukuyan AM
Year: 2019
Journal: Cancer Res
Title: Inactivation of Bap1 Cooperates with Losses of Nf2 and Cdkn2a to Drive the Development of Pleural Malignant Mesothelioma in Conditional Mouse Models.
Volume: 79
Issue: 16
Pages: 4113-4123
Publication
First Author: Chaney KE
Year: 2020
Journal: Cancer Res
Title: Cdkn2a Loss in a Model of Neurofibroma Demonstrates Stepwise Tumor Progression to Atypical Neurofibroma and MPNST.
Volume: 80
Issue: 21
Pages: 4720-4730
Publication
First Author: Hasan MK
Year: 2002
Journal: J Biol Chem
Title: CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.
Volume: 277
Issue: 40
Pages: 37765-70
Publication
First Author: Busch SE
Year: 2014
Journal: Oncogene
Title: ARF inhibits the growth and malignant progression of non-small-cell lung carcinoma.
Volume: 33
Issue: 20
Pages: 2665-73
Publication
First Author: Altomare DA
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice.
Volume: 106
Issue: 9
Pages: 3420-5
Publication
First Author: Hauer J
Year: 2011
Journal: Blood
Title: Loss of p19Arf in a Rag1(-/-) B-cell precursor population initiates acute B-lymphoblastic leukemia.
Volume: 118
Issue: 3
Pages: 544-53
Publication
First Author: Busch SE
Year: 2012
Journal: J Pathol
Title: ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.
Volume: 227
Issue: 3
Pages: 298-305
Publication
First Author: Luo C
Year: 2013
Journal: Cancer Res
Title: Loss of ARF sensitizes transgenic BRAFV600E mice to UV-induced melanoma via suppression of XPC.
Volume: 73
Issue: 14
Pages: 4337-48
Publication
First Author: Lindberg N
Year: 2014
Journal: J Neurosci
Title: Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Volume: 34
Issue: 44
Pages: 14644-51
Publication
First Author: Chapeau EA
Year: 2017
Journal: Proc Natl Acad Sci U S A
Title: Resistance mechanisms to TP53-MDM2 inhibition identified by in vivo piggyBac transposon mutagenesis screen in an Arf-/- mouse model.
Volume: 114
Issue: 12
Pages: 3151-3156
Publication
First Author: Fan Y
Year: 2024
Journal: Nat Commun
Title: Senescent-like macrophages mediate angiogenesis for endplate sclerosis via IL-10 secretion in male mice.
Volume: 15
Issue: 1
Pages: 2939
Publication
First Author: Wang J
Year: 2011
Journal: Mol Cancer Res
Title: Loss of Trop2 promotes carcinogenesis and features of epithelial to mesenchymal transition in squamous cell carcinoma.
Volume: 9
Issue: 12
Pages: 1686-95
Publication
First Author: Kamijo T
Year: 1997
Journal: Cell
Title: Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
Volume: 91
Issue: 5
Pages: 649-59
Publication
First Author: Yi Y
Year: 2004
Journal: Mol Biol Cell
Title: p19ARF determines the balance between normal cell proliferation rate and apoptosis during mammary gland development.
Volume: 15
Issue: 5
Pages: 2302-11
Publication
First Author: Churchman ML
Year: 2018
Journal: Cancer Cell
Title: Germline Genetic IKZF1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia.
Volume: 33
Issue: 5
Pages: 937-948.e8
Publication
First Author: Momcilovic M
Year: 2018
Journal: Cancer Cell
Title: The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma.
Volume: 33
Issue: 5
Pages: 905-921.e5
Publication
First Author: Carlson CM
Year: 2005
Journal: Proc Natl Acad Sci U S A
Title: Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.
Volume: 102
Issue: 47
Pages: 17059-64
Publication
First Author: Moreno-Miralles I
Year: 2005
Journal: J Biol Chem
Title: The inv(16) cooperates with ARF haploinsufficiency to induce acute myeloid leukemia.
Volume: 280
Issue: 48
Pages: 40097-103
Publication
First Author: Han SY
Year: 2017
Journal: Cancer Res
Title: Molecular Chaperone HSP90 Is Necessary to Prevent Cellular Senescence via Lysosomal Degradation of p14ARF.
Volume: 77
Issue: 2
Pages: 343-354
Publication
First Author: Viotti J
Year: 2014
Journal: Oncogene
Title: Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Volume: 33
Issue: 14
Pages: 1764-75
Publication
First Author: Knocke S
Year: 2016
Journal: Cell Rep
Title: Tailored Tumor Immunogenicity Reveals Regulation of CD4 and CD8 T Cell Responses against Cancer.
Volume: 17
Issue: 9
Pages: 2234-2246
Publication
First Author: Shao L
Year: 2014
Journal: Blood
Title: Total body irradiation causes long-term mouse BM injury via induction of HSC premature senescence in an Ink4a- and Arf-independent manner.
Volume: 123
Issue: 20
Pages: 3105-15
Publication
First Author: Gao X
Year: 2002
Journal: Cell Immunol
Title: Role of cell cycle regulator p19ARF in regulating T cell responses.
Volume: 219
Issue: 2
Pages: 119-30
Publication
First Author: Kamijo T
Year: 1999
Journal: Cancer Res
Title: Tumor spectrum in ARF-deficient mice.
Volume: 59
Issue: 9
Pages: 2217-22
Publication
First Author: Kim JB
Year: 2012
Journal: Circulation
Title: Effect of 9p21.3 coronary artery disease locus neighboring genes on atherosclerosis in mice.
Volume: 126
Issue: 15
Pages: 1896-906
Publication
First Author: Rudalska R
Year: 2014
Journal: Nat Med
Title: In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer.
Volume: 20
Issue: 10
Pages: 1138-46
Publication
First Author: Efeyan A
Year: 2006
Journal: Nature
Title: Tumour biology: Policing of oncogene activity by p53.
Volume: 443
Issue: 7108
Pages: 159
Publication
First Author: Apicelli AJ
Year: 2008
Journal: Mol Cell Biol
Title: A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.
Volume: 28
Issue: 3
Pages: 1068-80
Publication
First Author: Foster CJ
Year: 2002
Journal: Oncogene
Title: Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary gland.
Volume: 21
Issue: 22
Pages: 3525-31
Publication
First Author: Conkrite K
Year: 2012
Journal: J Clin Invest
Title: Cooperation between Rb and Arf in suppressing mouse retinoblastoma.
Volume: 122
Issue: 5
Pages: 1726-33
Publication
First Author: Sugihara E
Year: 2012
Journal: Oncogene
Title: Ink4a and Arf are crucial factors in the determination of the cell of origin and the therapeutic sensitivity of Myc-induced mouse lymphoid tumor.
Volume: 31
Issue: 23
Pages: 2849-61
Publication
First Author: García MA
Year: 2006
Journal: EMBO J
Title: Antiviral action of the tumor suppressor ARF.
Volume: 25
Issue: 18
Pages: 4284-92
Publication
First Author: Wang PY
Year: 2008
Journal: Blood
Title: The biologic properties of leukemias arising from BCR/ABL-mediated transformation vary as a function of developmental origin and activity of the p19ARF gene.
Volume: 112
Issue: 10
Pages: 4184-92
Publication
First Author: Frazier DP
Year: 2012
Journal: Cancer Res
Title: Dmp1 physically interacts with p53 and positively regulates p53's stability, nuclear localization, and function.
Volume: 72
Issue: 7
Pages: 1740-50
Publication
First Author: Boulos N
Year: 2011
Journal: Blood
Title: Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemia.
Volume: 117
Issue: 13
Pages: 3585-95
Publication
First Author: Krimpenfort P
Year: 2007
Journal: Nature
Title: p15Ink4b is a critical tumour suppressor in the absence of p16Ink4a.
Volume: 448
Issue: 7156
Pages: 943-6
Publication
First Author: Gargiulo G
Year: 2013
Journal: Cancer Cell
Title: In vivo RNAi screen for BMI1 targets identifies TGF-β/BMP-ER stress pathways as key regulators of neural- and malignant glioma-stem cell homeostasis.
Volume: 23
Issue: 5
Pages: 660-76
Publication
First Author: Machado E
Year: 2015
Journal: Sci Adv
Title: Regulated lysosomal exocytosis mediates cancer progression.
Volume: 1
Issue: 11
Pages: e1500603
Publication
First Author: Maeda T
Year: 2005
Journal: Nature
Title: Role of the proto-oncogene Pokemon in cellular transformation and ARF repression.
Volume: 433
Issue: 7023
Pages: 278-85
Publication
First Author: McKeller RN
Year: 2002
Journal: Proc Natl Acad Sci U S A
Title: The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.
Volume: 99
Issue: 6
Pages: 3848-53
Publication
First Author: Talos F
Year: 2005
Journal: Cancer Res
Title: Mitochondrially targeted p53 has tumor suppressor activities in vivo.
Volume: 65
Issue: 21
Pages: 9971-81
Publication
First Author: de Stanchina E
Year: 1998
Journal: Genes Dev
Title: E1A signaling to p53 involves the p19(ARF) tumor suppressor.
Volume: 12
Issue: 15
Pages: 2434-42
Publication
First Author: Wang P
Year: 2006
Journal: Oncogene
Title: Decreased Mdm2 expression inhibits tumor development induced by loss of ARF.
Volume: 25
Issue: 26
Pages: 3708-18
Publication
First Author: Volanakis EJ
Year: 2013
Journal: Exp Hematol
Title: Epigenetic regulation of the Ink4a-Arf (Cdkn2a) tumor suppressor locus in the initiation and progression of Notch1-driven T cell acute lymphoblastic leukemia.
Volume: 41
Issue: 4
Pages: 377-86
Publication
First Author: Kamijo T
Year: 1999
Journal: Cancer Res
Title: Loss of the ARF tumor suppressor reverses premature replicative arrest but not radiation hypersensitivity arising from disabled atm function.
Volume: 59
Issue: 10
Pages: 2464-9
Publication
First Author: Treanor LM
Year: 2014
Journal: J Exp Med
Title: Interleukin-7 receptor mutants initiate early T cell precursor leukemia in murine thymocyte progenitors with multipotent potential.
Volume: 211
Issue: 4
Pages: 701-13
Publication
First Author: Forys JT
Year: 2014
Journal: Cell Rep
Title: ARF and p53 coordinate tumor suppression of an oncogenic IFN-β-STAT1-ISG15 signaling axis.
Volume: 7
Issue: 2
Pages: 514-26
Publication
First Author: Li C
Year: 2013
Journal: Proc Natl Acad Sci U S A
Title: Arf tumor suppressor and miR-205 regulate cell adhesion and formation of extraembryonic endoderm from pluripotent stem cells.
Volume: 110
Issue: 12
Pages: E1112-21
Publication
First Author: Stepanova L
Year: 2005
Journal: Blood
Title: A limited role for p16Ink4a and p19Arf in the loss of hematopoietic stem cells during proliferative stress.
Volume: 106
Issue: 3
Pages: 827-32
Publication
First Author: Helmrich A
Year: 2005
Journal: Oncogene
Title: Recurrent chromosomal aberrations in INK4a/ARF defective primary lymphomas predict drug responses in vivo.
Volume: 24
Issue: 26
Pages: 4174-82
Publication
First Author: Park HJ
Year: 2011
Journal: EMBO Mol Med
Title: Deregulation of FoxM1b leads to tumour metastasis.
Volume: 3
Issue: 1
Pages: 21-34
Publication
First Author: Kopanja D
Year: 2018
Journal: Carcinogenesis
Title: p19Arf inhibits aggressive progression of H-ras-driven hepatocellular carcinoma.
Volume: 39
Issue: 3
Pages: 318-326
Publication
First Author: Bertwistle D
Year: 2007
Journal: Blood
Title: Regulation of the Arf tumor suppressor in Emicro-Myc transgenic mice: longitudinal study of Myc-induced lymphomagenesis.
Volume: 109
Issue: 2
Pages: 792-4
Publication
First Author: Volk EL
Year: 2009
Journal: Mol Cancer Res
Title: The MDM2-a splice variant of MDM2 alters transformation in vitro and the tumor spectrum in both Arf- and p53-null models of tumorigenesis.
Volume: 7
Issue: 6
Pages: 863-9
Publication
First Author: Vijayachandra K
Year: 2009
Journal: Mol Carcinog
Title: Induction of p16ink4a and p19ARF by TGFbeta1 contributes to growth arrest and senescence response in mouse keratinocytes.
Volume: 48
Issue: 3
Pages: 181-186
Publication
First Author: Sorrentino JA
Year: 2014
Journal: J Clin Invest
Title: p16INK4a reporter mice reveal age-promoting effects of environmental toxicants.
Volume: 124
Issue: 1
Pages: 169-73
Publication
First Author: Molofsky AV
Year: 2005
Journal: Genes Dev
Title: Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways.
Volume: 19
Issue: 12
Pages: 1432-7
Publication
First Author: Wigle JT
Year: 2002
Journal: EMBO J
Title: An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype.
Volume: 21
Issue: 7
Pages: 1505-13
Publication
First Author: Baker DJ
Year: 2008
Journal: Nat Cell Biol
Title: Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency.
Volume: 10
Issue: 7
Pages: 825-36
Publication
First Author: Hidalgo I
Year: 2012
Journal: Cell Stem Cell
Title: Ezh1 is required for hematopoietic stem cell maintenance and prevents senescence-like cell cycle arrest.
Volume: 11
Issue: 5
Pages: 649-62
Publication
First Author: Tu Q
Year: 2018
Journal: Oncogene
Title: CDKN2B deletion is essential for pancreatic cancer development instead of unmeaningful co-deletion due to juxtaposition to CDKN2A.
Volume: 37
Issue: 1
Pages: 128-138
Publication
First Author: Ulanet DB
Year: 2010
Journal: PLoS One
Title: Loss of p19(Arf) facilitates the angiogenic switch and tumor initiation in a multi-stage cancer model via p53-dependent and independent mechanisms.
Volume: 5
Issue: 8
Pages: e12454
Publication
First Author: Eischen CM
Year: 2002
Journal: Cancer Res
Title: Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.
Volume: 62
Issue: 7
Pages: 2184-91
Publication
First Author: King D
Year: 2002
Journal: Oncogene
Title: Loss of neurofibromatosis-1 and p19(ARF) cooperate to induce a multiple tumor phenotype.
Volume: 21
Issue: 32
Pages: 4978-82
Publication
First Author: Ruddell A
Year: 2008
Journal: Oncogene
Title: p19/Arf and p53 suppress sentinel lymph node lymphangiogenesis and carcinoma metastasis.
Volume: 27
Issue: 22
Pages: 3145-55
Publication
First Author: Moore L
Year: 2003
Journal: Oncogene
Title: Cooperativity of p19ARF, Mdm2, and p53 in murine tumorigenesis.
Volume: 22
Issue: 49
Pages: 7831-7
Publication
First Author: Eischen CM
Year: 2004
Journal: Oncogene
Title: Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development.
Volume: 23
Issue: 55
Pages: 8931-40
Publication
First Author: Gusarova GA
Year: 2007
Journal: J Clin Invest
Title: A cell-penetrating ARF peptide inhibitor of FoxM1 in mouse hepatocellular carcinoma treatment.
Volume: 117
Issue: 1
Pages: 99-111
Publication
First Author: Meng X
Year: 2016
Journal: Cancer Res
Title: RPL23 Links Oncogenic RAS Signaling to p53-Mediated Tumor Suppression.
Volume: 76
Issue: 17
Pages: 5030-9
Publication
First Author: Martin AC
Year: 2004
Journal: Invest Ophthalmol Vis Sci
Title: Pathogenesis of persistent hyperplastic primary vitreous in mice lacking the arf tumor suppressor gene.
Volume: 45
Issue: 10
Pages: 3387-96
Publication
First Author: Cullion K
Year: 2009
Journal: Blood
Title: Targeting the Notch1 and mTOR pathways in a mouse T-ALL model.
Volume: 113
Issue: 24
Pages: 6172-81
Publication
First Author: Ferletta M
Year: 2007
Journal: Mol Cancer Res
Title: Sox10 has a broad expression pattern in gliomas and enhances platelet-derived growth factor-B--induced gliomagenesis.
Volume: 5
Issue: 9
Pages: 891-7
Publication
First Author: Zhang Y
Year: 2019
Journal: PLoS One
Title: Chemotherapy-induced cellular senescence suppresses progression of Notch-driven T-ALL.
Volume: 14
Issue: 10
Pages: e0224172
Publication
First Author: Mikawa R
Year: 2018
Journal: Aging Cell
Title: Elimination of p19ARF -expressing cells protects against pulmonary emphysema in mice.
Volume: 17
Issue: 5
Pages: e12827
Publication  
First Author: Mikawa R
Year: 2020
Journal: Biomolecules
Title: p19Arf Exacerbates Cigarette Smoke-Induced Pulmonary Dysfunction.
Volume: 10
Issue: 3
Publication
First Author: Abdul-Aziz AM
Year: 2019
Journal: Blood
Title: Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
Volume: 133
Issue: 5
Pages: 446-456
Publication  
First Author: Kaur G
Year: 2021
Journal: Int J Mol Sci
Title: p16-3MR: A Novel Model to Study Cellular Senescence in Cigarette Smoke-Induced Lung Injuries.
Volume: 22
Issue: 9